Bio-Rad Labs (BIO) Tops Q2 EPS by 32c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mail
Get Alerts BIO Hot Sheet
Price: $369.95 +1.77%
EPS Growth %: -1.3%
Financial Fact:
Net income attributable to Bio-Rad: 18.01M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
EPS Growth %: -1.3%
Financial Fact:
Net income attributable to Bio-Rad: 18.01M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q2 EPS of $3.00, $0.32 better than the analyst estimate of $2.68. Revenue for the quarter came in at $681.1 million versus the consensus estimate of $697.96 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
- Preferred Bank (PFBC) Tops Q3 EPS by 4c
- Venture Global rises after QatarEnergy supply talks reported
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
